Nanoviricides Inc (NNVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,107 | -6,327 | -4,534 | -2,613 | -8,822 |
| Depreciation Amortization | 723 | 535 | 354 | 176 | 723 |
| Accounts payable and accrued liabilities | 41 | -35 | 89 | 590 | -711 |
| Other Working Capital | 215 | 124 | 254 | 701 | -540 |
| Other Operating Activity | 1,237 | 1,209 | 1,000 | 422 | 1,137 |
| Operating Cash Flow | $-5,891 | $-4,494 | $-2,838 | $-724 | $-8,214 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -324 | -249 | -210 | -24 | -239 |
| Investing Cash Flow | $-324 | $-249 | $-210 | $-24 | $-239 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | N/A | 16,564 |
| Other Financing Activity | -235 | -202 | -133 | -71 | -1,303 |
| Financing Cash Flow | $-235 | $-202 | $-133 | $-71 | $15,261 |
| Beginning Cash Position | 20,517 | 20,517 | 20,517 | 20,517 | 13,709 |
| End Cash Position | 14,066 | 15,572 | 17,336 | 19,697 | 20,517 |
| Net Cash Flow | $-6,450 | $-4,945 | $-3,181 | $-820 | $6,808 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,891 | -4,494 | -2,838 | -724 | -8,214 |
| Capital Expenditure | -324 | -249 | -210 | -24 | -239 |
| Free Cash Flow | -6,216 | -4,743 | -3,048 | -749 | -8,453 |